Dr. Reddy’s Laboratories Ltd. announced its unaudited financial results for the year ended March 31, 2009 under International Financial Reporting Standards (IFRS). Its FY09 contains following key points:

• Overall revenues at Rs. 69.4 billion ($1.4 billion) in FY09 as against Rs. 50.0 billion ($983 million) in FY08, representing a growth of 39%.

  
  

• The growth was driven by the successful launch of the authorized generic version of GlaxoSmithKline’s Imitrex

  
  
  Like

  Dislike
  
  

  Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

  "Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!